Stockscreener 앱 받기
5.67
4.42%
0.24
시간 외 거래:
5.55
-0.12
-2.12%
Cero Therapeutics Holdings Inc 주식(CERO)의 최신 뉴스
Risk Analysis: Should you avoid CERo Therapeutics Holdings Inc Equity Warrant stock right now2025 Sector Review & Daily Stock Trend Reports - خودرو بانک
Insider Sell: Will CERo Therapeutics Holdings Inc Equity Warrant outperform small cap indexes2025 Major Catalysts & Free Fast Entry Momentum Trade Alerts - خودرو بانک
Profit Review: Does Cass Information Systems Inc. have a competitive edgeStop Loss & Weekly High Conviction Ideas - خودرو بانک
Value Recap: How does CERo Therapeutics Holdings Inc score in quality rankings2025 Market Overview & Weekly High Return Stock Forecasts - خودرو بانک
Analyst Calls: Whats CERo Therapeutics Holdings Incs historical return2025 Growth vs Value & Technical Confirmation Alerts - خودرو بانک
Aug Ideas: Is CERo Therapeutics Holdings Inc likely to announce a buybackGap Down & Daily Technical Forecast Reports - خودرو بانک
Block Trades: Can CERo Therapeutics Holdings Inc Equity Warrant outperform in the next rallyJuly 2025 Summary & Reliable Intraday Trade Alerts - خودرو بانک
Breakouts Watch: Is CERo Therapeutics Holdings Inc Equity Warrant benefiting from interest rate changesWeekly Stock Recap & Reliable Volume Spike Alerts - خودرو بانک
Bank Watch: Is CERo Therapeutics Holdings Inc exposed to currency risks2025 Key Highlights & AI Powered Market Entry Ideas - خودرو بانک
Chipmakers Recap: Can CERo Therapeutics Holdings Inc outperform in the next rally2025 Retail Activity & Stock Portfolio Risk Management - خودرو بانک
EV Market: What drives UVSP’s stock priceInsider Buying & Accurate Intraday Trading Signals - خودرو بانک
Can CERo Therapeutics Holdings Inc deliver alphaWeekly Profit Summary & Community Trade Idea Sharing Platform - خودرو بانک
Aug Closing: What are analysts price targets for CERo Therapeutics Holdings IncWeekly Trend Report & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Aug Analyst Calls: Is CERo Therapeutics Holdings Inc.’s growth already priced inTrade Risk Summary & Weekly Market Pulse Alerts - خودرو بانک
Trade Recap: Can CERo Therapeutics Holdings Inc deliver consistent dividends2025 Market Outlook & Fast Moving Stock Trade Plans - خودرو بانک
Buyback Watch: Can CERo Therapeutics Holdings Inc be recession proof2025 Price Targets & Verified Stock Trade Ideas - خودرو بانک
CERo Therapeutics secures key patent protection for cancer therapy By Investing.com - Investing.com Australia
Is CERo Therapeutics Holdings Inc. likely to announce a buybackEarnings Recap Summary & Weekly Sector Rotation Insights - Lancaster City Council
Top 3 Health Care Stocks You'll Regret Missing In Q3 - Benzinga
CERo Therapeutics secures key patent protection for cancer therapy - Investing.com
CERo Therapeutics Receives Notice of Allowance from U.S. Patent and Trade Office on Composition of Matter and Method of Use for CER-1236 in Cancer with Expected Protection Through 2041 - The Manila Times
CERo Therapeutics Receives Notice of Allowance from U.S. - GlobeNewswire
Momentum Screeners Rank CERo Therapeutics Holdings Inc. Equity Warrant in Top 5 TodayFed Meeting & Weekly High Conviction Trade Ideas - beatles.ru
CERo Therapeutics Faces Nasdaq Delisting Risk - MSN
CERo Therapeutics Holdings Inc. Volume Confirms Breakout — Analysts BullishJuly 2025 Update & Community Verified Trade Alerts - beatles.ru
CERo Therapeutics Holdings Inc. Equity Warrant Stock Fails to Break Resistance Traders React2025 Technical Patterns & Free Low Drawdown Momentum Trade Ideas - beatles.ru
CERo Therapeutics administers second dose in AML clinical trial By Investing.com - Investing.com South Africa
Published on: 2025-09-08 20:17:23 - beatles.ru
CERo Therapeutics administers second dose in AML clinical trial - Investing.com
CERo Therapeutics Holdings Inc. Price Holds Above Key Fib Level2025 Market Sentiment & Risk Adjusted Buy/Sell Alerts - beatles.ru
CERo Therapeutics advances Phase 1 CER-1236 trial with dose intensification in AML - MarketScreener
CERo Therapeutics Announces Dose Intensification in Phase 1 Study of CER-1236 in Acute Myeloid Leukemia - GlobeNewswire
First-Ever TIM-4 Targeting Cell Therapy: CERo Therapeutics Advances AML Treatment with Doubled Dose Protocol - Stock Titan
Can CERo Therapeutics Holdings Inc. maintain its current growth rate2025 Momentum Check & Precise Entry and Exit Recommendations - beatles.ru
Is CERo Therapeutics Holdings Inc. being accumulated by smart moneyWeekly Profit Analysis & Weekly Consistent Profit Watchlists - خودرو بانک
Is CERo Therapeutics Holdings Inc. stock a good pick for beginnersMarket Growth Summary & High Accuracy Swing Entry Alerts - خودرو بانک
Published on: 2025-09-05 23:15:37 - خودرو بانک
What are CERo Therapeutics Holdings Inc. Equity Warrant’s growth leversJuly 2025 Reactions & Weekly High Potential Alerts - خودرو بانک
FDA grants fast track designation to CERo’s leukemia therapy By Investing.com - Investing.com Canada
What’s CERo Therapeutics Holdings Inc.’s historical returnWeekly Profit Summary & Entry Point Confirmation Alerts - خودرو بانک
Published on: 2025-09-06 00:07:46 - خودرو بانک
Energy Moves: Is CERo Therapeutics Holdings Inc. stock overvalued or fairly pricedTrade Performance Summary & Community Verified Trade Alerts - خودرو بانک
How to manage a losing position in CERo Therapeutics Holdings Inc.July 2025 Action & Long-Term Growth Stock Strategies - Newser
Historical volatility pattern of CERo Therapeutics Holdings Inc. visualized2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Will CERo Therapeutics Holdings Inc. bounce back from current support2025 Technical Patterns & Safe Entry Momentum Stock Tips - Newser
How to track smart money flows in CERo Therapeutics Holdings Inc. Equity Warrant2025 Support & Resistance & Momentum Based Trading Signals - Newser
Will CERo Therapeutics Holdings Inc. Equity Warrant outperform its industry peers2025 Technical Overview & Comprehensive Market Scan Insights - خودرو بانک
Published on: 2025-09-05 13:18:23 - Newser
CERo Therapeutics Gets Fast Track Designation For Experimental Cancer Drug, But Stock Tumbles – Here’s What Happened - Stocktwits
Is CERo Therapeutics Holdings Inc.’s growth already priced inMarket Growth Summary & Weekly Watchlist of Top Performers - خودرو بانک
CERo Therapeutics’ CER-1236: A High-Conviction Biotech Play with Accelerated Regulatory Pathways and Transformative AML Potential - AInvest
Risk adjusted return profile for CERo Therapeutics Holdings Inc. Equity Warrant analyzed2025 Earnings Impact & Verified Swing Trading Watchlists - Newser
Cero Therapeutics receives FDA fast track designation for CER-1236 in acute myeloid leukemia (AML) - MarketScreener
Is CERo Therapeutics Holdings Inc. undervalued by DCF analysis2025 Retail Activity & Daily Profit Maximizing Trade Tips - خودرو بانک
CERo Therapeutics Holdings Inc. recovery potential after sell off2025 Investor Takeaways & High Accuracy Swing Entry Alerts - Newser
CERo Therapeutics Gains Fast Track for AML Drug - TipRanks
CERo Therapeutics Says FDA Grants Fast Track Designation to Potential Leukemia Treatment - MarketScreener
FDA grants fast track designation to CERo’s leukemia therapy - Investing.com
CERo Therapeutics Receives FDA Fast Track Designation for CER-1236 in Acute Myeloid Leukemia - Quiver Quantitative
CERo Therapeutics Receives FDA Fast Track Designation for CER-1236 in Acute Myeloid Leukemia (AML) - GlobeNewswire
FDA Fast Track Designation: CERo's Novel Cancer Immunotherapy CER-1236 Advances Against Deadly AML - Stock Titan
Volatility clustering patterns for CERo Therapeutics Holdings Inc. Equity WarrantJuly 2025 Big Picture & Community Consensus Trade Signals - Newser
0.77%
1.53%
자본화:
|
볼륨(24시간):